Visualitzant VHIO - Articles científics per títol
Ara mostrant els elements 807-826 d 865
-
The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases
(MDPI, 2020-01-26) -
The target antigen determines the mechanism of acquired resistance to T cell-based therapies
(Cell Press, 2022-10-18) -
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers
(Nature Research, 2021-06-07) -
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
(Nature Portfolio, 2022-12-09) -
The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling
(Cell Press, 2022-09-13) -
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
(American Association for Cancer Research, 2022-12-16) -
Towards a cancer mission in Horizon Europe: recommendations
(Wiley, 2020-08) -
Towards evidence-based response criteria for cancer immunotherapy
(Nature Portfolio, 2023-05-24) -
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies
(American Society of Clinical Oncology, 2022-09-15) -
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies
(Oxford University Press, 2024-03) -
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis
(American Association for Cancer Research, 2022-12-01)